18 March 2024 - Medical equipment manufacturer Neupulse announced on Monday that it has secured USD3.2m seed funding led by Eos Advisory and US investors to advance world's first wearable device aimed at tackling Tourettes Syndrome (TS) and othe...
18 March 2024 - Biopharmaceutical company Bristol Myers Squibb (BMS) (NYSE:BMY) confirmed on Monday that it has completed its acquisition of biopharmaceutical company Karuna Therapeutics Inc (Nasdaq:KRTX), strengthening its neuroscience portfolio.Wit...
18 March 2024 - Clinical-stage biopharmaceutical company Faron Pharmaceuticals Ltd (AIM: FARN) (First North: FARON) shares additional positive data from the Phase 1 part of the BEXMAB trial, showcasing promising outcomes for higher-risk (HR) myelodys...
18 March 2024 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) on Monday revealed significant overall survival (OS) data from RUBY phase III trial, indicating the potential of Jemperli (dostarlimab) in combination therapies for primary advanced or...
18 March 2024 - Mathematical modelling and data science company Physiomics plc (AIM: PYC) announced on Monday that it has been awarded a significant contract by an existing pharma client, valued at GBP178,000.The project focuses on Pharmacokinetic-Ph...